FOLH1 and neoplasm: PET imaging and biodistribution experiments in mice bearing low PSMA-expressing tumors demonstrated significantly higher tumor uptake of this high molar activity radiotracer compared to conventional solution-phase radiolabeling products (Fig. 4).